logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
02/04/2026
Citibank recommends shorting the euro/ Hungarian forint before the elections in Hungary and going long on Hungarian bonds.
Latest
5 m ago
The Egyptian Minister of Finance announced that the purchasing price of local wheat will be increased to 2500 Egyptian pounds per kilogram.
7 m ago
NASA astronauts are about to embark on a journey around the moon, marking humanity's return to the vicinity of the moon for the first time in half a century.
9 m ago
US media: The US military has lost 16 MQ-9 "Reaper" drones.
9 m ago
Eli Lilly's oral weight loss drug in the United States has been approved, putting pressure on competitors Novo Nordisk. Eli Lilly's drug has been approved to help people lose weight or maintain previous weight loss results. The oral drug from Eli Lilly has been approved to help patients lose weight or maintain previous weight loss results. This review took less than four months thanks to a new project launched by the Food and Drug Administration (FDA) aiming to accelerate the market entry of drugs that meet national priorities, provide innovative therapies, or meet unmet medical needs. Eli Lilly is quickly catching up with Novo Nordisk, whose weight loss drug has been in high demand since its approval in December of last year. Eli Lilly has produced billions of doses of Foundayo to ensure quick market entry. Wall Street analysts predict that sales of this drug could reach $18 billion by 2030.
10 m ago
US storage chip stocks surged significantly.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.